| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $617.6M | -13.8% |
| Cost of Revenue | $180.9M | -19.9% |
| Gross Profit | $436.6M | -11.0% |
| R&D Expense | $170.4M | -11.1% |
| SG&A Expense | $217.8M | -9.2% |
| Operating Income | -$737.1M | -988.4% |
| Pre-tax Income | -$688.4M | -1468.2% |
| Income Tax | $148.7M | +362.8% |
| Net Income | -$837.1M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $161.5M | +18.9% |
| Short-term Investments | $154.2M | -20.6% |
| Accounts Receivable | $23.6M | -24.7% |
| Current Assets | $437.6M | +5.5% |
| Total Assets | $869.0M | -49.7% |
| Current Liabilities | $528.3M | +1.9% |
| Total Liabilities | $676.0M | -13.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $125.2M | -49.1% |
| Capital Expenditures | $75.0M | -9.8% |
| Investing Cash Flow | $11.3M | -95.8% |
| Financing Cash Flow | -$109.1M | +87.2% |
| Free Cash Flow | $50.3M | -69.2% |
| -4704.3% |
| EPS (Basic) | -$8.10 | -5162.5% |
| EPS (Diluted) | -$8.10 | -2282.4% |
| Stockholders' Equity |
| $193.0M |
| -79.6% |